Hridayesh Prakash, Ph.D is Associate Professor at Virology and Immunology Department, Amity University, India. Before starting his current position, he was Ramanujan Professor at University of Hyderabad during 2013-2017 and postdoctoral fellow in Germany during 2005-2013. His specializations are Tumor Immunology / Immunotherapy (lung and pancreatic cancer) and Cell based Immunotherapies, Host Apoptosis regulation, Signal Transduction, Pulmonary Infection Biology, Radiation Biology. His major research area is Immunotherapy of persistent Respiratory Infections and Gastric Cancer. He is unraveling therapeutic potential of macrophage against solid and established tumors and their contribution in various cancer directed interventions like radio / immune therapies. His second major interest is to understand how certain pathogens like H. pylori, Chlamydia and Mycobacteria sabotage host immunity with special emphasis on macrophage during chronic and persistent infections. Dr. Prakash has amply demonstrated that macrophages indeed represent potential target cell populations for translational medicine. He was able to demonstrate that adoptive transfer of tumor bearing mice with iNOs+ M1 macrophages offers an easy substitute of cumbersome high dose radiotherapy for the eradication of established, solid and refractory tumors of pancreas which is curse and death statement for the humankind. Within frame of this, he is also unraveling the impact of exchange of TAM with M1 macrophage on persistent infection driven cancer (adenocarcinoma) as well. He has published 39 papers including 3 book chapters. He received Young Scientist Award from Deference Research and Development organization, Govt of India and Ramanujan fellow award from Department of Science and Technology, Govt of India. Other than this Dr. Prakash is serving as member of Indian and German Immunology society. He is also serving as editorial board member of several international peer reviewed journals like F. Immunology, F. Microbiology. He has served as external reviewer for Austrian and Romanian Research Council and was a recipient of Travel from European society of Dermatological Research. Recently he has been elected as Fellow of Royal Society of Biology, London which is a caveat award conferred to him.